Concepedia

Mark Bartholomä

MB

51

Publications

2.4K

Citations

27

H-Index

2004

Active since

Affiliations

Saarland University(Current)

University of Freiburg

University Medical Center Freiburg

German Cancer Research Center

Syracuse University

Mark Bartholomä is an author at Saarland University specializing in medicine, engineering, and urology.

ORCID

Top concepts

Publications per year

2004–2024

51

Publications

51

Oncogenic JAK2 <sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 218 citations · Full text

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

Fadi Khreish, Niklas Ebert, Martin Ries et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 207 citations

, , +7

High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers

Michael Hettich, Friederike Braun, Mark Bartholomä et al. · Theranostics · 2016 · 191 citations · Full text

Complex Formation of ICL670 and Related Ligands with Fe<sup>III</sup> and Fe<sup>II</sup>

S. Steinhauser, Uwe Heinz, Mark Bartholomä et al. · European Journal of Inorganic Chemistry · 2004 · 169 citations

, , +13

Recent developments in the design of bifunctional chelators for metal-based radiopharmaceuticals used in Positron Emission Tomography

Mark Bartholomä · Inorganica Chimica Acta · 2012 · 127 citations

, , +10

Rows per page

1–5 of 51